国产精品久久久久久永久牛牛,55国产福利在线视频,成人午夜精品视频在线观看

目錄產品 » 穩定細胞系 » Human Recombinant Glucagon-like Peptide 1 Receptor Stable Cell Line
CHO-K1/GLP1R/Gα15 Stable Cell Line

Figure 1. GLP-1 (7-37)-induced concentration-dependent stimulation of intracellular calcium mobilization in CHO-K1/GLP1R/Gα15 cells. The cells were loaded with Calcium-4 prior to being stimulated with agonist GLP-1 (7-37). The intracellular calcium change was measured by FLIPRTETRA. The relative fluorescent units (RFU) were normalized and plotted against the log of the cumulative doses (5-fold dilution) of GLP-1 (7-37) (Mean ± SEM, n = 3). The EC50 of GLP-1 (7-37) on this cell was 0.14 μM.

Notes:
EC50 value is calculated with four parameter logistic equation:
Y=Bottom + (Top-Bottom)/(1+10^((LogEC50-X)*Hill Slope))
X is the logarithm of concentration. Y is the response
Y is % stimulation of RFU and starts at Bottom and goes to Top with a sigmoid shape.

CHO-K1/GLP1R/Gα15 Stable Cell Line

Figure 2. FACS analysis of cell surface expression of GLP1R on CHO-K1/GLP1R/Gα15 stable cell line. The fluorescence signal of the target protein on cell product (red) was compared to negative control (green) and detected with GLP1R Antibody (Cat. No. A01826, GenScript) followed by FITC conjugated Goat anti-Mouse IgG Antibody (H+L) (Cat. No. ab6785, Abcam).

CHO-K1/GLP1R/Gα15 Stable Cell Line

Figure 3. Dose dependent stimulation of intracellular cAMP mobilization upon treatment with calcitonin in CHO-K1/GLP1R/Gα15 cells. d2 acceptor fluorophore-labeled cAMP (Cat. No. 62AM4PEC; Revvity) and intracellular cAMP in CHO-K1/GLP1R/Gα15 cells competitively bind with Europium Cryptate-labeled anti-cAMP monoclonal antibody. The FRET signal decreases as the intracellular cAMP concentration rises and was measured by plate reader (Varioskan, Thermo Fisher). The EC50 of GLP-1 (7-37) was 1.84 nM.

CHO-K1/GLP1R/Gα15 Stable Cell Line

Recombinant CHO-K1 cells stably overexpress human glucagon-like peptide-1 receptor (GLP1R) on the surface and contain high levels of G protein Gαs to couple with the receptor in downstream signaling pathways.
M00451
詢價

聯系我們
Product Description Recombinant CHO-K1 cells stably overexpress human glucagon-like peptide-1 receptor (GLP1R) on the surface and contain high levels of G protein Gαs to couple with the receptor in downstream signaling pathways.
Culture Properties Adherent
Stability Stable through more than 16 passages with no significant changes in assay performance or expression profile.
Size Two vials of frozen cells (>1×106 per vial in 1 mL)
Storage Store cells in liquid nitrogen immediately upon receipt. Thaw and recover cells within one year from the date received.

Culture Medium Ham’s F-12K (Kaighn’s), 10% FBS, 200 μg/ml Zeocin (Cat. No. R250-01, Life Technologies), 100 μg/ml Hygromycin B (Cat. No. 10687010, Invitrogen)
Complete Growth Medium Ham’s F-12K (Kaighn’s), 10% FBS
Freeze Medium-DATA 45% Ham’s F-12K (Kaighn’s) (Cat. No. 21127, Life Technologies), 45% FBS (Cat. No. 10099-141, Gibco), 10% DMSO (Cat. No. D2650, Sigma)

  • CHO-K1/GLP1R/Gα15 Stable Cell Line
  • CHO-K1/GLP1R/Gα15 Stable Cell Line

    Figure 1. GLP-1 (7-37)-induced concentration-dependent stimulation of intracellular calcium mobilization in CHO-K1/GLP1R/Gα15 cells. The cells were loaded with Calcium-4 prior to being stimulated with agonist GLP-1 (7-37). The intracellular calcium change was measured by FLIPRTETRA. The relative fluorescent units (RFU) were normalized and plotted against the log of the cumulative doses (5-fold dilution) of GLP-1 (7-37) (Mean ± SEM, n = 3). The EC50 of GLP-1 (7-37) on this cell was 0.14 μM.

    Notes:
    EC50 value is calculated with four parameter logistic equation:
    Y=Bottom + (Top-Bottom)/(1+10^((LogEC50-X)*Hill Slope))
    X is the logarithm of concentration. Y is the response
    Y is % stimulation of RFU and starts at Bottom and goes to Top with a sigmoid shape.

  • CHO-K1/GLP1R/Gα15 Stable Cell Line
  • CHO-K1/GLP1R/Gα15 Stable Cell Line

    Figure 2. FACS analysis of cell surface expression of GLP1R on CHO-K1/GLP1R/Gα15 stable cell line. The fluorescence signal of the target protein on cell product (red) was compared to negative control (green) and detected with GLP1R Antibody (Cat. No. A01826, GenScript) followed by FITC conjugated Goat anti-Mouse IgG Antibody (H+L) (Cat. No. ab6785, Abcam).

  • CHO-K1/GLP1R/Gα15 Stable Cell Line
  • CHO-K1/GLP1R/Gα15 Stable Cell Line

    Figure 3. Dose dependent stimulation of intracellular cAMP mobilization upon treatment with calcitonin in CHO-K1/GLP1R/Gα15 cells. d2 acceptor fluorophore-labeled cAMP (Cat. No. 62AM4PEC; Revvity) and intracellular cAMP in CHO-K1/GLP1R/Gα15 cells competitively bind with Europium Cryptate-labeled anti-cAMP monoclonal antibody. The FRET signal decreases as the intracellular cAMP concentration rises and was measured by plate reader (Varioskan, Thermo Fisher). The EC50 of GLP-1 (7-37) was 1.84 nM.


For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.


喜歡新升級的網站嗎?

討厭

不喜歡

一般

喜歡

非常喜歡

*
    主站蜘蛛池模板: 西贡区| 轮台县| 新源县| 阿拉善左旗| 谢通门县| 富锦市| 盐池县| 武城县| 三原县| 吉木乃县| 克拉玛依市| 河南省| 大洼县| 庆城县| 福泉市| 林周县| 资源县| 雅安市| 克东县| 平和县| 平罗县| 缙云县| 通州区| 大英县| 凌海市| 鹤峰县| 宁化县| 石泉县| 平阳县| 海丰县| 扶余县| 蒙城县| 梁山县| 横峰县| 福建省| 酉阳| 中山市| 且末县| 渭南市| 丰都县| 尉氏县|